You cannot register for this meeting

Please join the District Addiction Consultation Service (DACS) for a PCSS-MOUD Half and Half training course. This course provides an overview of the FDA-approved medication buprenorphine prescribed for the treatment of opioid use disorder (OUD). The course trainer will conduct an overview of prevention, identification, and treatment of substance use disorders emphasizing OUD. The 8-hour buprenorphine training is offered in a ‘half and half’ format: 4 hours of in-person training followed by 4 hours of online training through the PCSS-MOUD portal that must be completed within 30 days of this course. Completion of both components of this training fulfil the 8-hour substance use training required for DEA registrants and renewals as mandated in the MATE Act. Learning Objectives: • Screen and identify patients with OUD and define evidence-based treatments • Discuss the pharmacology of opioids as it relates to treatment of opioid use disorder (OUD) patients • Describe the fundamentals of office-based opioid treatment including the treatment of the co-morbid patient • Explain the process of buprenorphine induction as well as stabilization and maintenance • Discuss all FDA approved antagonist and agonist medications to treat OUD • Discuss basic office protocols including medical record documentation and confidentiality • Utilize evidence-based resources to ensure providers have the confidence to prescribe buprenorphine for patients with OUD For information, please visit the Official Activity Announcement at: https://adobe.ly/4gL17za *Please make sure you type your email address correctly when registering. You must be logged into Zoom under the same name you used to register for the training. *New PCSS-MOUD Virtual Buprenorphine Training Procedures: All participants MUST have their video camera turned on for the entire training. Chat questions will be used during the training to confirm attendance and participation. Partial credit will NOT be awarded.